NCT05062096 Characterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metastatic Melanoma or as Adjuvant Therapy for High-risk of Recurrence Status UNKNOWN Phase NA
NCT05061940 This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols. Status TERMINATED Phase N/A
NCT05061537 Study of PF-07263689 in Participants With Selected Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05061134 A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05060432 Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05057013 A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05054062 Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients Status COMPLETED Phase NA
NCT05053555 High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies Status RECRUITING Phase NA
NCT05053230 A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer Status RECRUITING Phase NA
NCT05051865 To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma Status UNKNOWN Phase PHASE2
NCT05031494 A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers Status COMPLETED Phase PHASE2
NCT05029791 Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients Status RECRUITING Phase NA
NCT05027009 Effects of Simulated Solar Radiation on Human Skin in Preventing Skin Cancer Status COMPLETED Phase NA
NCT05013099 Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05004792 Dermoscopy Augmented Histology Trial, a Randomized Controlled Trial Status NOT_YET_RECRUITING Phase NA
NCT05003622 Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors Status COMPLETED Phase PHASE1
NCT05002569 A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma Status TERMINATED Phase PHASE3